Literature DB >> 4851128

Complications of carbenoxolone therapy.

G J Davies, J Rhodes, B J Calcraft.   

Abstract

Side effects from carbenoxolone are common and are due to electrolyte disturbance, such as sodium retention and hypokalaemia. They occur particularly in the elderly, who may already be being treated for other illnesses. Eight patients are described with serious side effects from carbenoxolone therapy, some of which were unrecognized for some time because of inadequate follow-up or because clinicians were unfamiliar with them.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4851128      PMCID: PMC1613145          DOI: 10.1136/bmj.3.5927.400

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  10 in total

1.  TREATMENT OF GASTRIC ULCER WITH CARBENOXOLONE SODIUM AND OESTROGENS.

Authors:  R DOLL; I D HILL; C F HUTTON
Journal:  Gut       Date:  1965-02       Impact factor: 23.059

2.  Treatment of gastric ulcer with carbenoxolone: antagonistic effect of spironolactone.

Authors:  R Doll; M J Langman; H H Shawdon
Journal:  Gut       Date:  1968-02       Impact factor: 23.059

3.  Carbenoxolone sodium in the treatment of gastric ulcer with special reference to side-effects.

Authors:  A G Turpie; T J Thomson
Journal:  Gut       Date:  1965-12       Impact factor: 23.059

4.  Treatment of gastric ulceration with carbenoxolone sodium: clinical and radiological evaluation.

Authors:  L Horwich; R Galloway
Journal:  Br Med J       Date:  1965-11-27

5.  Side effects of carbenoxolone sodium: a study of ambulant therapy of gastric ulcer.

Authors:  R D Montgomery
Journal:  Gut       Date:  1967-04       Impact factor: 23.059

6.  Hypokalaemia, flaccid quadruparesis, and myoglobinuria with carbenoxolone (biogastrone).

Authors:  S D Mohamed; R S Chapman; J Crooks
Journal:  Br Med J       Date:  1966-06-25

7.  Biochemical effects of short-term treatment with carbenoxolone disodium.

Authors:  W Hausmann; A L Tárnoky
Journal:  Br J Pharmacol Chemother       Date:  1966-02

8.  Hypokalaemia complicating carbenoxolone (duogastrone) therapy.

Authors:  A Muir; J A Laithwaite; W Wood
Journal:  Br Med J       Date:  1969-05-24

9.  Hypokalemia after treatment with duogastrone (carbenoxolone).

Authors:  M Swallow
Journal:  Br Med J       Date:  1969-07-26

10.  A double-blind trial of carbenoxolone sodium capsules in the treatment of duodenal ulcer.

Authors:  J M Cliff; G J Milton-Thompson
Journal:  Gut       Date:  1970-02       Impact factor: 23.059

  10 in total
  19 in total

Review 1.  Drugs in the treatment of gastric and duodenal ulcer.

Authors:  M J Langman
Journal:  Drugs       Date:  1977-08       Impact factor: 9.546

2.  Drugs for peptic ulcer. Invited commentary.

Authors:  M I Grossman
Journal:  World J Surg       Date:  1977-01       Impact factor: 3.352

3.  Carbenoxolone-induced hypokalaemia simulating Guillain-Barré syndrome.

Authors:  A Royston; B J Prout
Journal:  Br Med J       Date:  1976-07-17

Review 4.  Some aspects of medical management of gastrointestinal disease. I.

Authors:  B W Badley
Journal:  Can Med Assoc J       Date:  1975-01-25       Impact factor: 8.262

5.  Clinical picture of peptic ulceration diagnosed endoscopically.

Authors:  M C Sheppard; G K Holmes; R Cockel
Journal:  Gut       Date:  1977-07       Impact factor: 23.059

6.  Carbenoxolone sodium: its role in ulcer healing.

Authors:  M J Langman
Journal:  Drugs       Date:  1976       Impact factor: 9.546

7.  Treatment of peptic ulcer disease- a symposium.

Authors:  J H Meyer; A Schwabe; J I Isenberg; R A Sturdevant; M I Grossman; E Passaro
Journal:  West J Med       Date:  1977-04

8.  Rhabdomyolysis and acute tubular necrosis associated with carbenoxolone and diuretic treatment.

Authors:  C Descamps; J M Vandenbroucke; C van Ypersele de Strihou
Journal:  Br Med J       Date:  1977-01-29

9.  Comparison between cimetidine and Caved-S in the treatment of gastric ulceration, and subsequent maintenance therapy.

Authors:  A G Morgan; W A McAdam; C Pacsoo; A Darnborough
Journal:  Gut       Date:  1982-06       Impact factor: 23.059

Review 10.  Carbenoxolone: a review of its pharmacological properties and therapeutic efficacy in peptic ulcer disease.

Authors:  R M Pinder; R N Brogden; P R Sawyer; T M Speight; R Spencer; G S Avery
Journal:  Drugs       Date:  1976       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.